Amkay Products IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Apr 30 to May 03 2024
Price Band
₹52 - 55
Current GMP
₹104(89.09%)
Subscription
748.03 times
IPO Details
| IPO Date | April 30, 2024 to May 3, 2024 |
| Listing Date | Wednesday, May 8, 2024 |
| Face Value | ₹10 per share |
| Price Band | ₹52 to ₹55 per share |
| Lot Size | 2000 Shares |
| Total Issue Size | 2,292,000 shares (aggregating up to ₹12.61 Cr) |
| Fresh Issue | 2,292,000 shares (aggregating up to ₹12.61 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE SME |
| Share holding pre issue | 6,363,640 |
| Share holding post issue | 8,655,640 |
| Market Maker portion | 120,000 shares Hem Finlease |
IPO Date
April 30, 2024 to May 3, 2024
Listing Date
Wednesday, May 8, 2024
Face Value
₹10 per share
Price Band
₹52 to ₹55 per share
Lot Size
2000 Shares
Total Issue Size
2,292,000 shares (aggregating up to ₹12.61 Cr)
Fresh Issue
2,292,000 shares (aggregating up to ₹12.61 Cr)
Issue Type
Book Built Issue IPO
Listing At
BSE SME
Share holding pre issue
6,363,640
Share holding post issue
8,655,640
Market Maker portion
120,000 shares Hem Finlease
IPO Subscription Details
| Anchor Investors | 1 |
| Market Maker | 1 |
| Qualified Institutions | 173.04 |
| Non-Institutional Buyers*** | 987.34 |
| Retail Investors | 973.14 |
| Total ** | 748.03 |
Anchor Investors
1
Market Maker
1
Qualified Institutions
173.04
Non-Institutional Buyers***
987.34
Retail Investors
973.14
Total **
748.03
Day Wise Sub
| Day | QIB | NII* | Retail | Total |
|---|---|---|---|---|
| Day 1 Apr 30, 2024 | 0.06 | 37.60 | 54.14 | 35.18 |
| Day 2 May 2, 2024 | 0.79 | 216.49 | 332.51 | 213.07 |
| Day 3 May 3, 2024 | 173.04 | 987.34 | 973.14 | 748.03 |
DayDay 1
Apr 30, 2024
QIB0.06
NII*37.60
Retail54.14
Total35.18
DayDay 2
May 2, 2024
QIB0.79
NII*216.49
Retail332.51
Total213.07
DayDay 3
May 3, 2024
QIB173.04
NII*987.34
Retail973.14
Total748.03
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 08-05-2024 | 55.00 | 62(112.73%) | 117 |
| 07-05-2024 | 55.00 | 62(112.73%) | 117 |
| 06-05-2024 | 55.00 | 60(109.09%) | 115 |
| 05-05-2024 | 55.00 | 64(116.36%) | 119 |
| 04-05-2024 | 55.00 | 64(116.36%) | 119 |
| 03-05-2024 | 55.00 | 64(116.36%) | 119 |
| 02-05-2024 | 55.00 | 55(100.0%) | 110 |
| 01-05-2024 | 55.00 | 45(81.82%) | 100 |
| 30-04-2024 | 55.00 | 45(81.82%) | 100 |
| 29-04-2024 | 55.00 | 25(45.45%) | 80 |
| 28-04-2024 | 55.00 | 25(45.45%) | 80 |
| 27-04-2024 | 55.00 | 25(45.45%) | 80 |
| 26-04-2024 | 55.00 | 0(0.0%) | 55 |
| 25-04-2024 | 55.00 | 0(0.0%) | 55 |
| 24-04-2024 | 55.00 | 0(0.0%) | 55 |
Date08-05-2024
Price55.00
GMP62(112.73%)
Estimate List Price117
Date07-05-2024
Price55.00
GMP62(112.73%)
Estimate List Price117
Date06-05-2024
Price55.00
GMP60(109.09%)
Estimate List Price115
Date05-05-2024
Price55.00
GMP64(116.36%)
Estimate List Price119
Date04-05-2024
Price55.00
GMP64(116.36%)
Estimate List Price119
Date03-05-2024
Price55.00
GMP64(116.36%)
Estimate List Price119
Date02-05-2024
Price55.00
GMP55(100.0%)
Estimate List Price110
Date01-05-2024
Price55.00
GMP45(81.82%)
Estimate List Price100
Date30-04-2024
Price55.00
GMP45(81.82%)
Estimate List Price100
Date29-04-2024
Price55.00
GMP25(45.45%)
Estimate List Price80
Date28-04-2024
Price55.00
GMP25(45.45%)
Estimate List Price80
Date27-04-2024
Price55.00
GMP25(45.45%)
Estimate List Price80
Date26-04-2024
Price55.00
GMP0(0.0%)
Estimate List Price55
Date25-04-2024
Price55.00
GMP0(0.0%)
Estimate List Price55
Date24-04-2024
Price55.00
GMP0(0.0%)
Estimate List Price55
IPO Important Dates
| IPO Open Date | Tuesday, April 30, 2024 |
| IPO Close Date | Friday, May 3, 2024 |
| Basis of Allotment | Monday, May 6, 2024 |
| Initiation of Refunds | Tuesday, May 7, 2024 |
| Credit of Shares to Demat | Tuesday, May 7, 2024 |
| Listing Date | Wednesday, May 8, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on May 3, 2024 |
IPO Open Date
Tuesday, April 30, 2024
IPO Close Date
Friday, May 3, 2024
Basis of Allotment
Monday, May 6, 2024
Initiation of Refunds
Tuesday, May 7, 2024
Credit of Shares to Demat
Tuesday, May 7, 2024
Listing Date
Wednesday, May 8, 2024
Cut-off time for UPI mandate confirmation
5 PM on May 3, 2024
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹110,000 |
| Retail (Max) | 1 | 2000 | ₹110,000 |
| HNI (Min) | 2 | 4,000 | ₹220,000 |
ApplicationRetail (Min)
Lots1
Shares2000
Amount₹110,000
ApplicationRetail (Max)
Lots1
Shares2000
Amount₹110,000
ApplicationHNI (Min)
Lots2
Shares4,000
Amount₹220,000
Financial Information
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 1,887.52 | 1,563.77 | 1,580.64 |
| Revenue | 2,385.56 | 2,825.05 | 3,679.45 |
| Profit After Tax | 215.34 | 151.02 | 146.71 |
| Net Worth | 986.96 | 771.62 | 620.60 |
| Reserves and Surplus | 350.59 | 743.95 | 592.93 |
| Total Borrowing | 476.22 | 469.98 | 433.59 |
Period EndedPeriod Ended
31 Dec 202331 Dec 2023
31 Mar 202331 Mar 2023
31 Mar 202231 Mar 2022
Period EndedAssets
31 Dec 20231,887.52
31 Mar 20231,563.77
31 Mar 20221,580.64
Period EndedRevenue
31 Dec 20232,385.56
31 Mar 20232,825.05
31 Mar 20223,679.45
Period EndedProfit After Tax
31 Dec 2023215.34
31 Mar 2023151.02
31 Mar 2022146.71
Period EndedNet Worth
31 Dec 2023986.96
31 Mar 2023771.62
31 Mar 2022620.60
Period EndedReserves and Surplus
31 Dec 2023350.59
31 Mar 2023743.95
31 Mar 2022592.93
Period EndedTotal Borrowing
31 Dec 2023476.22
31 Mar 2023469.98
31 Mar 2022433.59
Key Performance Indicator
| ROE | 24.49% |
| ROCE | 21.54% |
| Debt/Equity | 0.48 |
| RoNW | 21.82% |
| P/BV | 3.55 |
| PAT Margin (%) | 9.47 |
| EPS (Rs) | 2.37 |
ROE
24.49%
ROCE
21.54%
Debt/Equity
0.48
RoNW
21.82%
P/BV
3.55
PAT Margin (%)
9.47
EPS (Rs)
2.37
IPO Reservation
| Anchor Investor Shares Offered | 650,000 (28.36%) |
| Market Maker Shares Offered | 120,000 (5.24%) |
| QIB Shares Offered | 434,000 (18.94%) |
| NII (HNI) Shares Offered | 326,000 (14.22%) |
| Retail Shares Offered | 762,000 (33.25%) |
| Total Shares Offered | 2,292,000 (100%) |
Anchor Investor Shares Offered
650,000 (28.36%)
Market Maker Shares Offered
120,000 (5.24%)
QIB Shares Offered
434,000 (18.94%)
NII (HNI) Shares Offered
326,000 (14.22%)
Retail Shares Offered
762,000 (33.25%)
Total Shares Offered
2,292,000 (100%)
Information about company
Incorporated in October 2007, Amkay Products Limited is a company that produces and sells a wide range of healthcare products including medical devices, disposables, and other essential items such as face masks, alcohol swabs, lancet needles, nebulizers, pulse oximeters, surgeon caps, and more. Their products are used by healthcare centers, hospitals/clinics, nursing homes, and other such facilities across India.
The company manufactures and markets products such as diapers, plastic gloves, and suction machines.
The company offers over 30 healthcare products, including medical devices for respiratory diseases, surgical disposables, home healthcare products, and others. We manufacture 20 products and brand/trade 10 others.
The manufacturing facility, which occupies an area of about 26000 sq. ft., is fully equipped with machines, a testing lab, and other handling equipment to ensure a smooth process. The company is also accredited under the ISO 9001:2015 standard by QRO Certification LLP for its quality management system.
The company has two manufacturing unit situated in Thane, Maharashtra and a Wearhouse situated in Thane Maharastra.
As of December 31, 2023, the company has employed about 75 employees across different levels of the organization.
Objectives of IPO
The company intends to utilize the proceeds of the Issue to meet the following objectives:
Funding Capital Expenditure towards the installation of additional Machinery;
To meet working capital requirements; and
General Corporate Purpose.
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App